Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$182.74 USD
-6.52 (-3.44%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $182.58 -0.16 (-0.09%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $0.77 | 15.96% |
Earnings Summary
For their last quarter, Krystal Biotech (KRYS) reported earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.50 per share. This reflects a positive earnings surprise of 72.00%. Look out for KRYS's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of $0.77 per share, reflecting a year-over-year increase of 214.93%.
Earnings History
Price & Consensus
Zacks News for KRYS
RCKT Completes Enrollment in Rare Heart Disease Study, Stock Rises
KRYS: What are Zacks experts saying now?
Zacks Private Portfolio Services